Validation pour Ingenuity307

vers la météo de la validation par utilisateur

Ingenuity307

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 52 - PMID ?

In SP glioma cell lines , agonist monoclonal anti SP NODE protein antibody increases ( in a dose dependent manner ) expression of SP NODE protein .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                                          +-------------OBJ:V-N-------------+                                                                           
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              +--------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+     
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+     
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |        +MOD_ATT:N-+           |       +MOD_ATT+     
       |      |     |    |        |         |       |     |       |       |        |        |              |      |        |          |           |       |       |     
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a dose dependent manner ) expression of __SP__ __NODE__ protein .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 1

                                                          +--------------------------------COMP:V-N(in)-------------------------------+                                 
                                                          +-------------OBJ:V-N-------------+                                         |                                 
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              +--------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+     
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      +----MOD_ATT:N-N----+           +-MOD_ATT:N-ADJ-+     
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |        +MOD_ATT:N-+           |       +MOD_ATT+     
       |      |     |    |        |         |       |     |       |       |        |        |              |      |        |          |           |       |       |     
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a dose dependent manner ) expression of __SP__ __NODE__ protein .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-N (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 2

                                                          +-------------OBJ:V-N-------------+                                                                           
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              +--------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+     
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ-+     
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |        +MOD_ATT:N-+           |       +MOD_ATT+     
       |      |     |    |        |         |       |     |       |       |        |        |              |      |        |          |           |       |       |     
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a dose dependent manner ) expression of __SP__ __NODE__ protein .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 3

                                                          +-------------OBJ:V-N-------------+                                                                           
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                                         +--------COMP:N-N(of)-------+     
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ-+     
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      +---MOD_ATT:N-ADJ---+           |       +MOD_ATT+     
       |      |     |    |        |         |       |     |       |       |        |        |              |      |                   |           |       |       |     
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a dose dependent manner ) expression of __SP__ __NODE__ protein .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 4

                                                          +--------------------------------COMP:V-N(in)-------------------------------+                                 
                                                          +-------------OBJ:V-N-------------+                                         |                                 
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+              +--------MOD_ATT:N-N-------+--------COMP:N-N(of)-------+     
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              |      +---MOD_ATT:N-ADJ---+           +-MOD_ATT:N-ADJ-+     
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      |        +MOD_ATT:N-+           |       +MOD_ATT+     
       |      |     |    |        |         |       |     |       |       |        |        |              |      |        |          |           |       |       |     
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a dose dependent manner ) expression of __SP__ __NODE__ protein .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
MOD_ATT:N-N (expression,manner)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 5

                                                          +--------------------------------COMP:V-N(in)-------------------------------+                                 
                                                          +-------------OBJ:V-N-------------+                                         |                                 
       +--MOD_ATT:N-ADJ--+----------COMP:V-N(In)----------+       +------MOD_ATT:N-ADJ------+                                         +--------COMP:N-N(of)-------+     
       |      +MOD_ATT:N-+        +---MOD_ATT:N-N---+     |       |       +---MOD_ATT:N-N---+              +--------MOD_ATT:N-N-------+           +-MOD_ATT:N-ADJ-+     
       |      |     +MOD_+        |         +MOD_ATT+SUBJ:+       |       |        +MOD_ATT:+              |      +---MOD_ATT:N-ADJ---+           |       +MOD_ATT+     
       |      |     |    |        |         |       |     |       |       |        |        |              |      |                   |           |       |       |     
 In __SP__ glioma cell lines , agonist monoclonal anti __SP__ __NODE__ protein antibody increases ( in a dose dependent manner ) expression of __SP__ __NODE__ protein .
MOD_ATT:N-ADJ (line,__SP__)
MOD_ATT:N-N (line,glioma)
MOD_ATT:N-N (line,cell)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (anti,monoclonal)
COMP:V-N(In) (__SP__,line)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,increase)
COMP:V-N(in) (__SP__,expression)
MOD_ATT:N-ADJ (increase,__NODE__)
MOD_ATT:N-N (increase,protein)
MOD_ATT:N-N (increase,antibody)
MOD_ATT:N-N (expression,dose)
MOD_ATT:N-ADJ (expression,dependent)
COMP:N-N(of) (expression,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)